M Ventures

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

RRRené Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKLKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Co-investorsBABain Capital Life SciencesBABay City CapitalF-F-Prime CapitalMRMRL Ventures FundRARA CapitalRIRiverVest Venture Partners+9 more

Anjuna develops software for secure data sharing and confidential computing in cloud and AI environments.

AI & Machine LearningCloud ComputingCybersecurityDeep TechEnterprise SoftwareSan Francisco, US

AYAyal Yogev(CEO)inSteve WeisYMYan Michalevsky(CTO)in

BoardPBPeter Barrett(Director)inLJLonne Jaffe(Director)in

Co-investorsINInsight PartnersSISINEWAVE VENTURESALAlpha Intelligence CapitalDCDCVC (Data Collective)DODorm RoomFOFounder Collective+11 more

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.

BiotechDeep TechMedical DevicesCulver City, US

James Heath(Director)Leroy Hood(Director)AJAndreas Jurgeit(Director)inHeather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)

Co-investorsLELegend CapitalASAsset Management CompanyASAsset Management Ventures

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)TLTerry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in

Co-investorsARARCH Venture PartnersNONorthpond VenturesILIllumina VenturesNONovalis LifeSciences

BiotechGreenville, US

KWKevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Board seatHGHakan Goker· per SEC Form D

Co-investorsHAHatteras Venture PartnersILIllumina VenturesMCMC Healthcare VenturesPAPappas CapitalSVSV Health InvestorsABAbbVie+2 more

Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.

BiotechDeep TechHardwareMedical DevicesCambridge, GB

DRDr Ruizhi Wang(CEO)

Co-investorsCACambridge Angels groupBUBusiness Growth FundR4R42 GroupTHThe Engine VenturesUNUniversity of Cambridge EnterpriseUNUntitled Ventures

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Darshan Dalal(Chief Medical Officer)in

Co-investorsHAHadean VenturesINInnovestor VenturesSOSofinnova Partners4B4BIO CapitalBIBioqube Ventures

Akili Interactive develops digital therapeutics that use video game-based interventions to target attentional control deficits in patients with ADHD, delivered through proprietary technology featuring adaptive difficulty algorithms.

AI & Machine LearningDigital HealthGamingHealthtechMedical Devices

Co-investorsDGDG Daiwa VenturesDGDG Ventures, Inc.EVEvidity Health CapitalJAJAZZ Venture PartnersMAMachina VenturesRERevelation Partners+1 more

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsALAlpana VenturesDADaniel GutenbergEIEisai Innovation, Inc.HIHikma VenturesPOPolytech Ecosystem VenturesVIVI Partners+3 more

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable.

BiotechHealthtechLeiden, NL

Birgit Zech(CEO)in

Co-investorsTATaiho Ventures, LLCBIBioqube VenturesINInkef

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.

BiotechHealthtechMedical Devices

Co-investorsANAndera PartnersDEDementia Discovery FundNONovartis Venture FundPFPfizer Venture InvestmentsRARA CapitalSOSofinnova Partners+6 more

Biotech

Co-investorsKUKurma PartnersSOSofinnova PartnersJOJohnson & Johnson Innovation – JJDCSRSR One Capital ManagementEQEQT Life Sciences

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency.

BiotechDeep TechMedical DevicesParis, FR

Jérémie Laurent(Chief Executive Officer)

Co-investorsADAdBio partnersJOJohnson & Johnson Innovation – JJDC

beeOLED develops blue OLED emitters based on rare-earth (lanthanide) metal complexes, such as cerium or europium, stabilized with organic ligands and made vacuum-vaporizable for OLED display manufacturing.

Deep TechHardwareNew Materials

DCDr. Carsten RotheDr. Volodymyr Senkovskyy

Co-investorsECeCAPITAL ENTREPRENEURIAL PARTNERSINInnovation IndustriesECeCapital Entrepreneurial Partners AGHTHTGF

Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.

BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US

JTJared Tangney(Co-founder)inRYRich Yang(Co-founder)inEdward Kliphuis(Director)

BoardDBDaniel Bradbury(Director)inLGLana Ghanem(Director)

Co-investorsALAlpha Wave GlobalRIRiverVest Venture PartnersABAble PartnersAPAphelion CapitalAVAverin CapitalBEBeyond Capital+7 more

CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).

BiotechPhiladelphia, US

SKSteven Kelly(Executive Officer, Director)in

BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)RHRegina Hodits(Director)in

Co-investorsAGAgent CapitalAJAju IB InvestmentANAnzu PartnersGRGrazia Equity GmbHHEHealthCapMRMRL Ventures Fund+3 more

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.

AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US

Preetinder Virk(Chief Operating Officer)DLDavid Lazovsky(Founder)inKelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)inDave Lazovsky(Founder)Preet Virk(Founder)

Co-investorsFIFitz Gate VenturesIAIAG Capital PartnersIMimec.xpandKOKoch Disruptive TechnologiesSASamsung Catalyst FundTHThe Engine Ventures+11 more

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.

BiotechDeep TechHardwareMedical DevicesAtlanta, US

AZAlla Zamarayeva(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)TSTodd Sulchek(CSO & Co-founder)inAAAlex Alexeev(Co-founder)in

Co-investorsDYDynamk CapitalCOCota CapitalCRCreative Destruction Lab (CDL)ELElm Street VenturesEMEmbark VenturesGRGreatPoint Ventures+1 more

ChemPower develops an abrasive-free chemical mechanical planarization (CMP) technology and materials for advanced semiconductor chip manufacturing.

Advanced ManufacturingCleantechNew MaterialsSemiconductorsBeaverton, US

SMSudhanshu Misra(CEO)inSV Babu(CTO)

BoardSSSCOTT SHAW(Director)inOWEN LOZMAN(Director)JFJESSICA FREYER(Director)inBABU SURYADEVARA(Director)

Co-investorsFOFoothill VenturesINIn-Q-TelINIntel CapitalPAPangaea Ventures Us Inc.POPortland Seed FundRHRhapsody Venture Partners+3 more

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition.

AI & Machine LearningBiotechDeep TechCambridge, US

JKJared Kehe(Executive Officer, Director)inCACheri Ackerman(Executive Officer, Director)inBCBernardo Cervantes(Executive Officer, Director)inVSVera Schroeder(Director)in

BoardSLSarah Luppino(Director)in

Co-investorsALAlumni VenturesEXExcelestar VenturesGOGolden SeedsHOHorizons VenturesISISVMAMassVentures+4 more

Corvic offers an enterprise AI platform that wraps frontier models with grounded playbooks, multi-agent workflows, persistent memory, and secure data handling to process structured and unstructured data at scale.

AI & Machine LearningData & InfrastructureEnterprise Software

GGGurbinder Gill(Founder)in

Co-investorsFOFoothill VenturesLALam CapitalSPSprout OakATAtlantic Bridge VenturesBOBosch VenturesK2K2 Access Fund+1 more

Cyllene Therapeutics develops a gene therapy platform based on non-replicative Herpes Simplex Virus 1 (nrHSV-1) vectors to deliver DNA medicines for patients with severe localized chronic diseases.

BiotechDeep TechDigital Health

Co-investorsSCSCI VenturesANAndera PartnersBPBpifrance

DISCO develops a cell surfaceome discovery technology platform for identifying surface-bound proteins and protein communities in cancer cells, enabling the design of targeted therapies including mono- and bi-specific antibodies.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesUnknown from page, DE

Johannes Heuckmann, PhD(Co-Founder & Chief Operating Officer)

DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.

BiotechDeep TechHardwareParis, FR

TYThomas Ybert(Founder)inXGXavier Godronin

Co-investorsCACatalio Capital Management, LPCOCoatue ManagementILIllumina VenturesKUKurma PartnersSOSofinnova PartnersCACasdin Capital

Co-investorsANAndera PartnersFOFountain Healthcare PartnersPMPMV

Electroninks develops and manufactures metal complex inks for semiconductor packaging, consumer electronics, and medical device manufacturing, offering improved conductivity and sustainability compared to traditional metallized inks.

Advanced ManufacturingHardwareNew MaterialsSemiconductorsAustin, US

Co-investorsBABandgap VenturesINIn-Q-Tel

Enara Bio discovers and validates Dark Antigens from non-coding genomic regions to identify novel cancer targets, and develops first-in-class bispecific T-cell engagers against these targets through its EnTiCE platform.

BiotechDeep TechMedical Devices

George Kassiotis(Co-founder)Drew Pardoll(Co-founder)HAHouman Ashrafian(Co-founder)in

Co-investorsRARA CapitalSASamsara BioCapitalSVSV Health InvestorsPFPfizer VenturesDEDementia Discovery FundPFPfizer Venture Investments

FMC is a semiconductor company developing non-volatile memory solutions, spun from EU research institutions with R&D and manufacturing operations across Europe, the US, Japan, and Taiwan.

Deep TechHardwareSemiconductorsDresden, DE

TRThomas Rueckes(Chief Executive Officer)inAAAyman Abouelwafa(Chief Product Officer)inNANorm Armour(Chief Operating Officer)inRJRaj Jammy(President Global BU & CTO)in

Co-investorsBOBosch VenturesDEDeepTech & Climate FondsIMimec.xpandTETEL Venture Capital, Inc.HVHV CapitalUNUniversal Materials Incubator+2 more

Formo is a biotechnology company using fermentation and microbiology to create animal-free dairy products through molecular recreation rather than plant-based mimicry.

BiotechClimate TechFoodTechFrankfurt, DE

RaffaBritta Winterberg(Founder)Raffael Wohlgensinger(Founder)

Co-investorsAGAgronomicsFOFoodLabsGOGood Seed VenturesGRGrazia Equity GmbHGRGrey Silo VenturesLOLowercarbon Capital+5 more

FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors.

BiotechDeep TechHealthtechBasel, CH

TBTarig Bashir(Chief Executive Officer (CEO))inJWJens Würthner(Chief Medical Officer (CMO))FZFrank Zenke(Chief Scientific Officer (CSO))in

Co-investorsNONovartis Venture FundPFPfizer Venture InvestmentsOMOmega Funds

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health.

AI & Machine LearningBiotechDigital HealthFemTechHealthtech

RBRene Bharti(Co-founder)inDr. Dan Nayot(Co-founder)

Co-investorsSASandpiper VenturesWHWhitecap Venture PartnersGAGaingels

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

JJJennifer Jarrett(Chief Executive Officer & Board Director)inSSSherwin Sattarzadeh(Chief Operating Officer)inBHBecker Hewes(Chief Medical Officer)GWGarrett Winslow(General Counsel)inJBJim Baker(Chief Corporate Affairs Officer)inBBBrian Burkavage(Senior Vice President, Finance)in

Co-investorsEIEIR VenturesHAHadean VenturesSESEED Capital DenmarkSESeventure PartnersSUSunstone CapitalYSYsios Capital+3 more

The site promotes the Mostbet mobile application, a gambling app offering sports betting, casino games, poker, and eSports wagering for Android and iOS users.

ConsumerGamingLos Angeles, US

AMAlexander Mistakidis(CEO)inCMCarter Minshull(CTO)in

Co-investorsY Y CombinatorINIndex VenturesMAMaC Venture CapitalRIRiot GamesSKSkycatcher Fund

Genies creates AI personas with visual avatars that can be customized and deployed across various applications, games, websites, and brands, functioning as AI companions, NPCs, and enterprise agents.

AI & Machine LearningConsumerGamingLos Angeles, US

ANAkash Nigam(Founder)inEREvan Rosenbaum(Founder)inAkash Nigam Evan Rosenbaum(Founder)

Co-investorsA.A.Capital VenturesBABase Venture Management, Inc.BOBond Capital ManagementBRBreyer CapitalCOCoinbase VenturesCOCoinFund+28 more

Genopore is developing a single-molecule protein identification and quantitation system that uses chemo-selective protein labeling, solid-state nanopore translocation, and AI-powered optical readout to sequence whole proteins without mass spectrometry or affinity-based methods.

AI & Machine LearningBiotechDeep Tech

AMAmit Meller(Co-Founder and Director)OMOren Mansour(Co-founder & COO)inYLYigal Leiba(Co-founder & VP R&D)inRey Mali(CEO)ASAviv Sagi(CFO)inANAriel Notcovich(CPO)

IKAS (埃克斯工业) develops self-controlled smart manufacturing solutions for the semiconductor industry, including CIM systems, AI big-data systems, and an industrial Co-pilot covering process optimization, intelligent scheduling, and yield improvement.

Advanced ManufacturingAI & Machine LearningSemiconductorsBeijing, CN

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.

AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR

Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)Yann Gaston-Mathe(Founder)

Co-investorsDEDebiopharm Innovation FundOMOmnes Capital

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

PPPeretz Partensky(Executive Officer, Director)inSAStuart Alexander Jacobson(Executive Officer, Director)NHNina Horowitz(Chief Executive Officer)inRTRui Tostoes(Chief Technology Officer)inAJAlicia Jackson(Director)in

BoardDMDylan Morris(Director)in

Co-investorsNFNFXPIPioneerGAGaingelsHEHealthspan CapitalINInsight PartnersONOne Way Ventures+1 more

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLBLaura Brass(Director)inKWKai Wucherpfennig(Director)

Co-investorsAGAgent CapitalDCDC Investment PartnersLILifelinkLOLongwood FundMEMedical Excellence CapitalNONovartis Venture Fund+5 more

Inthera Bioscience AG is a biotech company with expertise spanning target discovery, drug discovery, medicinal chemistry, preclinical and toxicology work, and early clinical development.

BiotechDeep Tech

Mark Krul(Board of Directors)inKarl Rothweiler(Board of Directors)Martin Bonde(Board of Directors)

Co-investorsFOForbion

iOmx Therapeutics is a biotech company developing novel cancer therapies.

AI & Machine LearningBiotechHealthtechMedical DevicesMunich, DE

Co-investorsSOSofinnova PartnersMIMIG Capital AG

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

CPCatherine Pickering(Co-Founder & CEO)inLVLars van der Veen(Co-Founder & CSO)inMLMichael Lahn(CMO)inEHElizabeth Holt(CBO)inSSSteven Sciuto(CFO)inMTMichelle Tsai(COO)in

Co-investorsINInkef3B3B Future Health FundVIVI PartnersXGXGEN VentureJOJohnson & Johnson Innovation – JJDC

IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.

Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE

BBene(Co-Founder & Managing Director)inMonty(Co-Founder & Managing Director)

Co-investorsSESeed Fonds AachenTETechVision FondsTETechVision Fund

Kivu Bioscience develops antibody-drug conjugate (ADC) therapeutics in clinical development, advancing a pipeline of cancer treatments through strategic partnerships and collaborations.

BiotechDeep TechHealthtechMedical Devices

MTMohit Trikha(CEO)inSRSophia Randolph(Chief Medical Officer)in

Co-investorsBIBioGeneration VenturesBOBOMGIGimvHEHealthCapRERed Tree VentureNONovo Holdings

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJFJames Field(Founder)in

Co-investorsACAcequia Capital (AceCap)AIAir Street CapitalATAtomicoBABackedBEBeast VenturesCHChampion Hill Ventures+9 more

LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.

AI & Machine LearningBiotechDeep Tech

LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.

AI & Machine LearningBiotechDeep TechCambridge, US

GLGregory L. Verdine(Executive Officer, Director)GVGregory Verdine, Ph.D.

BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)

Co-investorsARARCH Venture PartnersGVGV (Google Ventures)RARA CapitalAIAisling CapitalALAlexandriaBEBezos Expeditions+7 more

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investors+N+ND CapitalILIllumina VenturesLOLongwall Venture Partners LLPOMOMX VenturesARARCH Venture Partners

Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.

BiotechDeep TechMedical DevicesCambridge, GB

Co-investorsARARCH Venture PartnersILIllumina VenturesPEPerscitus LLP+N+ND CapitalOMOMX Ventures

Lucidean develops optical interconnect technology, marketed as CohZero, aimed at improving coherent performance for AI data centers.

AI & Machine LearningDeep TechHardware

AMAaron Maharry(Cofounder and Co-CTO)inHAHector Andrade(Cofounder and Co-CTO)inClint Schow(Cofounder and Advisor)inLCLarry Coldren(Cofounder and Advisor)inJames Raring(President and CEO)in

Co-investorsCOCollaborative FundENEntrada VenturesFOFoothill VenturesRARaptor Group

Lumiode develops wafer-level μLED technology for ultra high-brightness, low-cost micro-displays used in wearable, automotive, and industrial products.

Deep TechHardwareSemiconductorsNew York, US

Nena Golubovic(Director)Vincent Lee(Executive Officer, Director)Ioannis Kymissis(Executive Officer, Director)Mark Halfman(Director)

BoardMBMichael Burychka(Director)in

Co-investorsANAnzu PartnersBLBlueRed Partners

Manticore Games develops and publishes Out of Time, a co-op roguelite video game, and operates the Core Platform, a user-generated content platform for games and interactive experiences.

Creator EconomyGamingSan Mateo, US

FDFrederic Descamps(Founder)inJMJordan Maynard(Founder)inCWChristian Wilson(Chief Technology Officer)inMCMatt Camp(Head of Product)in

BoardMLMitch Lasky(Director)in

Co-investors35359 CapitalATAtlassian VenturesBIBitkraft Esports VenturesCOCorrelation VenturesMAMaC Venture CapitalPRPROOF+5 more

Mass Appeal is a media company focused on hip-hop culture, producing content and products including new music releases in partnership with Sony Music, photography, and cultural events.

Media & EntertainmentNew York, US

Peter Bittenbender(Director)David M. Mars(Director)

Co-investorsMAMaC Venture CapitalWHWhite Owl Capital

Medisafe is a medication engagement platform that helps pharmaceutical companies connect with patients beyond the prescription and improve treatment adherence.

Digital HealthHealthtechMedical DevicesBoston, US

RSRotem Shor(Founder)in

Co-investors7W7wire VenturesALALIVE Israel HealthTech FundCOCorewell Health VenturesLOLool VenturesOCOctopus VenturesQUQualcomm Ventures+3 more

MemryX develops edge AI accelerator hardware and software solutions designed for efficient deployment across embedded systems.

AI & Machine LearningDeep TechHardwareSemiconductorsAnn Arbor, US

DWDr. Wei Lu(Co-founder)

Co-investorsELeLab VenturesHEHemi Ventures, Llc

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

FCFederico Capasso(Co-founder)inRDRob Devlin(Co-Founder and CEO)in

BoardXSXuhui Shao(Director)in

Co-investorsBABantam GroupBRBraemar Energy VenturesFOFoothill VenturesGLGlobal BrainINIntel CapitalNENeotribe Ventures+5 more

Micropsi Industries develops MIRAI, an AI-based vision and control system that trains industrial robots to handle tasks with variance, such as picking and insertion, and to adapt to changing factory conditions.

Advanced ManufacturingAI & Machine LearningRobotics

RVRonnie Vuine(Founder)in

Co-investorsASAsgard - human Capital for AICOConvergeCOcoparionPRProject A VenturesVSVsquared VenturesAHAhren Innovation Capital+3 more

Mighty offers SecretSauce, an AI tool that learns a brand's style from a URL, brand guidelines, or mood board to generate on-brand assets.

AI & Machine LearningMarketing TechSaaSSingapore, SG

SDSimon Davis(Founder)in

Co-investorsFEFermionMAMaC Venture CapitalPLPlay VenturesSKSkycatcher FundANAncient8ATAtlas Ventures+14 more

Mosa Meat is a company developing cultivated meat.

BiotechClimate TechFoodTech

MPMark Post(Founder)Mark W. Post(Founder)Peter Verstrate(Founder)

Co-investorsAGAgronomicsARArcTern VenturesBLBlue Horizon CorporationCOCollateral GoodLOLowercarbon CapitalMBMbuyu Capital Partners+8 more